CH1335392721
CH1335392721
GALDERMA GROUP N
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.241.000.000 | 4.440.000.000 | 18.0% |
| Cost of Revenue | 1.632.000.000 | 1.355.000.000 | 20.4% |
| Gross Profit | 3.609.000.000 | 3.085.000.000 | 17.0% |
| 2.733.000.000 | 2.407.000.000 | 13.5% | |
| Operating Income | 876.000.000 | 678.000.000 | 29.2% |
| Pretax Income | 638.000.000 | 310.000.000 | 105.8% |
| Net Income Common Stockholders | 613.000.000 | 231.000.000 | 165.4% |
| -- | -- | -- | |
| -- | -- | -- |